» Authors » Sidney Carrillo

Sidney Carrillo

Explore the profile of Sidney Carrillo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 150
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rerolle F, Jacobson J, Gueye C, Bennett A, Carrillo S, Ntuku H, et al.
Sci Rep . 2024 Mar; 14(1):7160. PMID: 38531921
Cattle herders and agricultural workers have been identified has key high-risk populations for malaria in northern Namibia. Population size estimates for these groups are lacking but are important for planning,...
2.
Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al.
Nature . 2021 Aug; 596(7872):E8. PMID: 34341540
No abstract available.
3.
Tsitsiklis A, Zha B, Byrne A, DeVoe C, Levan S, Rackaityte E, et al.
Res Sq . 2021 May; PMID: 34013247
Secondary bacterial infections, including ventilator-associated pneumonia (VAP), lead to worse clinical outcomes and increased mortality following viral respiratory infections including in patients with coronavirus disease 2019 (COVID-19). Using a combination...
4.
Tsitsiklis A, Zha B, Byrne A, DeVoe C, Rackaityte E, Levan S, et al.
medRxiv . 2021 Apr; PMID: 33791731
Secondary bacterial infections, including ventilator-associated pneumonia (VAP), lead to worse clinical outcomes and increased mortality following viral respiratory infections including in patients with coronavirus disease 2019 (COVID-19). Using a combination...
5.
Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al.
Nature . 2021 Jan; 591(7848):124-130. PMID: 33494096
Although infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has pleiotropic and systemic effects in some individuals, many others experience milder symptoms. Here, to gain a more comprehensive understanding...
6.
Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al.
bioRxiv . 2020 Nov; PMID: 33140050
One Sentence Summary: In severe COVID-19 patients, the immune system fails to generate cells that define mild disease; antibodies in their serum actively prevents the successful production of those cells.
7.
Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al.
Res Sq . 2020 Nov; PMID: 33140041
While SARS-CoV-2 infection has pleiotropic and systemic effects in some patients, many others experience milder symptoms. We sought a holistic understanding of the severe/mild distinction in COVID-19 pathology, and its...